КОМПАНИЯ SCI PHARMTECH INC

Location: Taiwan

Business Type: Manufacturer (Factory)

Company Introduction:

SCI PHARMTECH INC is a reputable pharmaceutical company based in Taiwan, established in 1988. It operates primarily as a manufacturer, focusing on the research, development, production, and sales of high-quality Active Pharmaceutical Ingredients (APIs) and advanced pharmaceutical intermediates. The company is committed to adhering to stringent international quality standards, including current Good Manufacturing Practices (cGMP), to ensure the safety and efficacy of its products. SCI PHARMTECH INC serves a global clientele, supplying essential components to various pharmaceutical companies worldwide, contributing to the development of innovative and life-saving medicines. Their core expertise lies in complex chemical synthesis and process optimization for pharmaceutical compounds.

SCI Pharmtech Inc., based in Taiwan, produces and offers the following products and services:

1. Active Pharmaceutical Ingredients (APIs)

2. High Potency Active Pharmaceutical Ingredients (HPAPIs)

3. Pharmaceutical Intermediates

4. Custom Synthesis Services

5. Contract Development and Manufacturing Organization (CDMO) Services

Specific examples of Active Pharmaceutical Ingredients (APIs) manufactured include:

- Oncology APIs: Gefitinib, Erlotinib, Imatinib, Lapatinib, Sunitinib, Sorafenib, Dasatinib, Nilotinib, Pazopanib, Regorafenib, Alectinib, Osimertinib.

- Cardiovascular APIs: Rivaroxaban, Apixaban, Dabigatran Etexilate, Ticagrelor.

- Central Nervous System (CNS) APIs: Donepezil, Memantine, Rotigotine.

- Antiviral APIs: Sofosbuvir, Ledipasvir, Velpatasvir, Tenofovir Alafenamide.

- Anti-diabetic APIs: Canagliflozin, Dapagliflozin, Empagliflozin, Sitagliptin, Linagliptin.

- Other APIs: Tacrolimus, Everolimus, Mycophenolate Mofetil, Febuxostat, Udenafil, Tofacitinib.